New ‘life changing’ asthma drug approved by regulators
Trials of a new asthma drug show that it could prove life changing for many people – who would only need two jabs a year. The long acting treatment by GSK – called depe-mok-imab – was shown to cut hospital admissions by 72%, while there were very few side …